Active: new fund May 2025 Verified 4 Nov 2026
Preface Ventures
New York early-stage firm that backs exited founders building enterprise infrastructure and software, investing at pre-seed and seed.
- Type
- VC firm
- Location
- New York, New York, United States
- Stages
- Pre-seed, Seed, Series A
- Backs
- B2B software, Fintech
- Sectors
- Healthtech and life sciences, Fintech, HR, B2B, SaaS and software
- Fund size / AUM
- $56.6M Preface Ventures IV (Form D offering, 2025)
- Latest fund or filing
- 30 Sep 2026
- Portfolio mix
- B2B software 78%; Fintech 22% (n=5)
- Website
- prefaceventures.com
Fund filings (SEC Form D)
- Latest fund on file
- Preface Ventures IV-A
- Filed
- 30 Sep 2026 (amendment)
- Fund size
- $57M (total offering)
- Fund vehicles filed in the last 12 months
- 2 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For Preface Ventures, the paid file holds: 1 named decision-maker with roles; check size; LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
Andrew McLeod @ CertnShikhar ShresthaMalinka Walaliyadde @ Alpha HealthAdvisory BoardCore Values
Sources
- www.sec.gov/Archives/edgar/data/2067580/000206758026000003/
- www.prefaceventures.com/
- www.sec.gov/Archives/edgar/data/2067576/000206757626000003/
- www.prefaceventures.com/about
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 57 lists
Future of work investors in New York (15)Series A future of work investors in the US (29)B2B investors in New York (34)Series A future of work investors (44)Series A investors in New York (49)Pre-seed future of work investors in the US (52)Pre-seed future of work investors (70)Seed future of work investors in the US (78)Series A B2B investors in the US (79)Pre-seed investors in New York (82)Pre-seed B2B investors in the US (86)Fintech investors in New York (98)Healthtech investors in New York (100)Seed future of work investors (105)Future of work venture capital firms in the US (118)Seed investors in New York (128)SaaS investors in New York (138)Series A fintech investors in the US (145)Pre-seed B2B investors (155)Series A B2B investors (157)Future of work investors (158)Series A healthtech investors in the US (164)Seed B2B investors in the US (183)Pre-seed fintech investors in the US (187)Pre-seed healthtech investors in the US (225)Series A SaaS investors in the US (256)B2B venture capital firms in the US (257)Series A fintech investors (294)Seed B2B investors (302)Pre-seed fintech investors (323)Seed fintech investors in the US (349)Pre-seed SaaS investors in the US (367)Series A investors in the US (372)Series A healthtech investors (401)Pre-seed healthtech investors (408)Seed healthtech investors in the US (437)B2B investors (438)Venture capital firms in New York (440)Series A SaaS investors (475)Fintech venture capital firms in the US (525)Pre-seed investors in the US (549)Pre-seed SaaS investors (562)Seed fintech investors (584)Seed SaaS investors in the US (666)Healthtech venture capital firms in the US (709)Seed healthtech investors (800)Fintech investors (846)Series A investors (864)Pre-seed investors (988)Seed SaaS investors (1,010)Seed investors in the US (1,043)SaaS venture capital firms in the US (1,049)Healthtech investors (1,207)SaaS investors (1,529)Active venture capital firms in the US (1,574)Seed investors (1,892)Venture capital firms in the US (2,975)